84 related articles for article (PubMed ID: 15743321)
1. Increased norepinephrine-associated adrenomedullary inclusions in Parkinson's disease.
Sugie M; Goto J; Kawamura M; Ota H
Pathol Int; 2005 Mar; 55(3):130-6. PubMed ID: 15743321
[TBL] [Abstract][Full Text] [Related]
2. Clinical and neuropathological correlates of Lewy body disease.
Hishikawa N; Hashizume Y; Yoshida M; Sobue G
Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
[TBL] [Abstract][Full Text] [Related]
3. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
Braak H; Sastre M; Del Tredici K
Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
[TBL] [Abstract][Full Text] [Related]
4. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
5. Neuronal inclusions in sporadic motor neuron disease are negative for alpha-synuclein.
Sasaki S; Komori T; Iwata M
Neurosci Lett; 2006 Apr 10-17; 397(1-2):15-9. PubMed ID: 16406315
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
7. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
[TBL] [Abstract][Full Text] [Related]
8. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
9. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.
Meredith GE; Halliday GM; Totterdell S
Parkinsonism Relat Disord; 2004 Jun; 10(4):191-202. PubMed ID: 15120093
[TBL] [Abstract][Full Text] [Related]
10. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
[TBL] [Abstract][Full Text] [Related]
12. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
14. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
Braak H; de Vos RA; Bohl J; Del Tredici K
Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease.
Klos KJ; Josephs KA; Parisi JE; Dickson DW
Mov Disord; 2005 Nov; 20(11):1515-20. PubMed ID: 16035099
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
[TBL] [Abstract][Full Text] [Related]
17. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.
Braak H; Bohl JR; Müller CM; Rüb U; de Vos RA; Del Tredici K
Mov Disord; 2006 Dec; 21(12):2042-51. PubMed ID: 17078043
[TBL] [Abstract][Full Text] [Related]
18. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Chu Y; Kordower JH
Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
20. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
